The Relationship Between Statins and Prostate Cancer Prevention
Abstract
among men in the United States. Few risk factors and strategies for prostate cancer prevention are known. Some evidence suggests that statins, a class of medications that reduce cholesterol, may reduce the incidence and progression of prostate cancer. Dr. Farwell is obtaining training that will allow him to investigate the relationship between statins and prostate cancer incidence and progression. He has taken classes at the Harvard School of Public Health and is having regular meetings with researchers at the Brigham and Women's Hospital and the VA Boston Healthcare System. He is assembling datasets and writing research plans that will allow him to investigate the relationship between statins and prostate cancer incidence, grade, and progression. During the past year, Dr. Farwell has made substantive progress toward becoming an independent investigator in the field of prostate cancer prevention.
Document Details
- Document Type
- Technical Report
- Publication Date
- Sep 01, 2009
- Accession Number
- ADA521810
Entities
People
- Wildon R. Farwell
Organizations
- Brigham and Women's Hospital